Blumberg Scott exercised Options for 846 Ceribell shares at $9.41 per share and sold 846 shares at $25 on Sep 15, 2026. The transactions left 147,446 and 146,600 shares, respectively, while a derivative-securities exercise left 51,802, giving investors the post-transaction holdings and stated percentages.
Key Highlights
- Blumberg Scott held 146,600 Ceribell shares after selling 846 shares on Sep 15, 2026.
- The option exercise price was $9.41 per share.
- The derivative-securities transaction represented about 1.6% of the prior holding.
Blumberg Scott exercised options for 846 shares of Ceribell, Inc. (NASDAQ: CBLL) on Sep 15, 2026, and sold 846 shares the same day. The option exercise was priced at $9.41 per share, while the sale took place at $25 per share. The transactions were recorded under SEC codes M and S.
Ceribell Share and Derivative Holdings
Following the option exercise, Blumberg Scott held 147,446 Ceribell shares. That transaction represented about 0.6% of the resulting shares holding. The subsequent sale left Blumberg Scott with 146,600 shares, while the sale represented about 0.6% of the prior shares holding. A separate M-coded entry covered 846 derivative securities. Blumberg Scott owned 51,802 derivative securities after that transaction.
FAQs
Q: How many Ceribell shares did Blumberg Scott transact?
A: Blumberg Scott exercised options for 846 Ceribell shares and sold 846 shares. Post-transaction holdings were 147,446 shares after the exercise and 146,600 after the sale.
Q: What prices were used in Blumberg Scott’s Ceribell transactions?
A: The option exercise used $9.41 per share. The separate sale was priced at $25 per share under the M and S transaction codes, respectively.
Q: How many derivative securities did Blumberg Scott hold afterward?
A: The option exercise covered 846 Ceribell derivative securities. Blumberg Scott owned 51,802 derivative securities afterward, and the transaction represented about 1.6% of the prior holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.